On Friday, Eyenovia Inc (NASDAQ: EYEN) opened lower -8.25% from the last session, before settling in for the closing price of $0.12. Price fluctuations for EYEN have ranged from $0.08 to $2.57 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 125.00% annually for the last half of the decade. Company’s average yearly earnings per share was noted 6.06% at the time writing. With a float of $109.29 million, this company’s outstanding shares have now reached $111.42 million.
In an organization with 57 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -4716.41%, operating margin of -109178.31%, and the pretax margin is -118845.16%.
Eyenovia Inc (EYEN) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Eyenovia Inc is 1.92%, while institutional ownership is 11.96%. The most recent insider transaction that took place on Aug 28 ’24, was worth 14,077. In this transaction Chief Executive Officer of this company bought 27,071 shares at a rate of $0.52, taking the stock ownership to the 109,998 shares. Before that another transaction happened on Aug 26 ’24, when Company’s Chief Executive Officer bought 50,000 for $0.57, making the entire transaction worth $28,500. This insider now owns 82,927 shares in total.
Eyenovia Inc (EYEN) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 6.06% per share during the next fiscal year.
Eyenovia Inc (NASDAQ: EYEN) Trading Performance Indicators
Check out the current performance indicators for Eyenovia Inc (EYEN). In the past quarter, the stock posted a quick ratio of 0.53. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 375.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.73, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.46 in one year’s time.
Technical Analysis of Eyenovia Inc (EYEN)
Let’s dig in a bit further. During the last 5-days, its volume was 117.77 million. That was better than the volume of 47.7 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 31.65%. Additionally, its Average True Range was 0.03.
During the past 100 days, Eyenovia Inc’s (EYEN) raw stochastic average was set at 3.84%, which indicates a significant decrease from 22.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 173.12% in the past 14 days, which was lower than the 240.27% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2334, while its 200-day Moving Average is $0.6218. However, in the short run, Eyenovia Inc’s stock first resistance to watch stands at $0.1169. Second resistance stands at $0.1238. The third major resistance level sits at $0.1347. If the price goes on to break the first support level at $0.0991, it is likely to go to the next support level at $0.0882. The third support level lies at $0.0813 if the price breaches the second support level.
Eyenovia Inc (NASDAQ: EYEN) Key Stats
There are currently 111,425K shares outstanding in the company with a market cap of 11.26 million. Presently, the company’s annual sales total 4 K according to its annual income of -27,260 K. Last quarter, the company’s sales amounted to 20 K and its income totaled -11,050 K.
